{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:34:31Z","timestamp":1772120071272,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s40264-022-01226-8","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T14:02:40Z","timestamp":1661608960000},"page":"1099-1109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Prospective Observational Study on BBV152 Coronavirus Vaccine Use in Adolescents and Comparison with Adults: Interim Results of the First Real-World Safety Analysis"],"prefix":"10.1007","volume":"45","author":[{"given":"Upinder","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anju","family":"K.L","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayank","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agniva","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta","family":"Kansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaibhav","family":"Jaisawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishor","family":"Patwardhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7737-0016","authenticated-orcid":false,"given":"Sankha Shubhra","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,27]]},"reference":[{"key":"1226_CR1","unstructured":"World Health Organization. Interim statement on COVID-19 vaccination for children and adolescents. https:\/\/www.who.int\/news\/item\/24-11-2021-interim-statement-on-covid-19-vaccination-for-children-and-adolescents."},{"key":"1226_CR2","unstructured":"US FDA. Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic [Internet]. https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use [cited 2022 Apr 7]."},{"key":"1226_CR3","unstructured":"China.org.cn. Sinovac COVID-19 vaccine safe for children, adolescents [Internet]. http:\/\/www.china.org.cn\/china\/2021-07\/02\/content_77602836.htm [cited 2022 Apr 7]."},{"key":"1226_CR4","doi-asserted-by":"crossref","unstructured":"Vadrevu KM, Reddy S, Jogdand H, Ganneru B, Mirza N, Tripathy VN, et al. Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (BBV152) in children from 2 to 18\u00a0years of age: an open-label, age-de-escalation phase 2\/3 study. medRxiv [Internet]. 2021;2021.12.28.21268468. http:\/\/medrxiv.org\/content\/early\/2021\/12\/29\/2021.12.28.21268468.abstract.","DOI":"10.1101\/2021.12.28.21268468"},{"key":"1226_CR5","unstructured":"Kaur U, Anju KL, Chauhan M, Joshi A, Kansal S, Jaisawal V, et al. A prospective observational study on BBV152 coronavirus vaccine use in adolescents and comparison with adults- first real-world safety analysis. medRxiv [Internet]. 2022;2022.04.08.22273634. http:\/\/medrxiv.org\/content\/early\/2022\/04\/10\/2022.04.08.22273634.abstract."},{"key":"1226_CR6","unstructured":"MoHFW. Guidelines for COVID-19 vaccination of children between 15-18 years and precaution dose to HCWs, FLWs & 60+ population with comorbidities [Internet]. https:\/\/www.mohfw.gov.in\/pdf\/GuidelinesforCOVID19VaccinationofChildrenbetween15to18yearsandPrecautionDosetoHCWsFLWs&60populationwithcomorbidities.pdf [cited 2022 Apr 7]."},{"key":"1226_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1473-3099(20)30942-7","volume":"21","author":"R Ella","year":"2021","unstructured":"Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021;21:637\u201346.","journal-title":"Lancet Infect Dis"},{"key":"1226_CR8","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(21)02000-6","volume":"398","author":"R Ella","year":"2021","unstructured":"Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, et al. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. Lancet. 2021;398:2173\u201384.","journal-title":"Lancet"},{"key":"1226_CR9","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","volume":"384","author":"NH Schultz","year":"2021","unstructured":"Schultz NH, S\u00f8rvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021;384:2124\u201330.","journal-title":"N Engl J Med"},{"key":"1226_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001472","author":"R Singh","year":"2022","unstructured":"Singh R, Chakrabarti SS, Gambhir IS, Verma A, Kumar I, Ghosh S, et al. Acute cardiac events after ChAdOx1 nCoV-19 corona virus vaccine: report of three cases. Am J Ther. 2022. https:\/\/doi.org\/10.1097\/MJT.0000000000001472.","journal-title":"Am J Ther"},{"key":"1226_CR11","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1002\/jmv.27742","volume":"94","author":"R Singh","year":"2022","unstructured":"Singh R, Kaur U, Singh A, Chakrabarti SS. Refractory hyper-eosinophilia associated with newly diagnosed rheumatoid arthritis following inactivated BBV152 COVID-19 vaccine. J Med Virol. 2022;94:3482\u20137.","journal-title":"J Med Virol"},{"key":"1226_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.vaccine.2021.12.044","volume":"40","author":"Y June Choe","year":"2022","unstructured":"June Choe Y, Yi S, Hwang I, Kim J, Park Y-J, Cho E, et al. Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents. Vaccine. 2022;40:691\u20134.","journal-title":"Vaccine"},{"key":"1226_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac103","author":"M Heshin-Bekenstein","year":"2022","unstructured":"Heshin-Bekenstein M, Ziv A, Toplak N, Hagin D, Kadishevich D, Butbul YA, et al. Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications. Rheumatology (Oxford). 2022. https:\/\/doi.org\/10.1093\/rheumatology\/keac103.","journal-title":"Rheumatology (Oxford)"},{"key":"1226_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa2107456","volume":"385","author":"RW Frenck","year":"2021","unstructured":"Frenck RW, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N Engl J Med. 2021;385:239\u201350.","journal-title":"N Engl J Med"},{"key":"1226_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101038","volume":"38","author":"U Kaur","year":"2021","unstructured":"Kaur U, Ojha B, Pathak BK, Singh A, Giri KR, Singh A, et al. A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers\u2014first results from India. EClinicalMedicine. 2021;38: 101038.","journal-title":"EClinicalMedicine"},{"key":"1226_CR16","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/jmv.27655","volume":"94","author":"SP Parida","year":"2022","unstructured":"Parida SP, Sahu DP, Singh AK, Alekhya G, Subba SH, Mishra A, et al. Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India. J Med Virol. 2022;94:2453\u20139.","journal-title":"J Med Virol"},{"key":"1226_CR17","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/S1473-3099(21)00070-0","volume":"21","author":"R Ella","year":"2021","unstructured":"Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021;21:950\u201361.","journal-title":"Lancet Infect Dis"},{"key":"1226_CR18","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/S1473-3099(21)00319-4","volume":"21","author":"B Han","year":"2021","unstructured":"Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1\/2 clinical trial. Lancet Infect Dis. 2021;21:1645\u201353.","journal-title":"Lancet Infect Dis"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-022-01226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-022-01226-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-022-01226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T13:35:06Z","timestamp":1663767306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-022-01226-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,27]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1007\/s40264-022-01226-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.04.08.22273634","asserted-by":"object"}]},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,27]]},"assertion":[{"value":"7 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been corrected. Supplementary materials were missing from this article and have now been uploaded.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding support.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No human experimentation was performed. All procedures were performed as per the Declaration of Helsinki and its further modifications. Study was conducted after permission from Institute Ethics Committee of the Institute of Medical Sciences, Banaras Hindu University (Ethical Approval number: Dean\/2022\/EC\/3210 and Dean\/2021\/EC\/2526).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent\/assent obtained from all participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent\/assent obtained from all participants.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Since this is a preliminary analysis, associated data may be made available by the corresponding author on reasonable\u00a0request, following applicable regulations.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"UK: Planned the study, designed the study methodology, supervised data collection and data verification, conducted the review of the literature, performed the statistical analysis, and drafted the first version of the article. AKL, MC, AJ, AD: Assisted in the review of the literature and data collection and recording. SK: Planned the study and supervised data collection. VJ, KP: Supervised data collection and data verification and assisted in the review of the literature. SSC: Supervised the study, assisted in data verification and visualization, and edited the final version of manuscript. All authors read and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}